The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Market Size Of The Pharmacovigilance And Drug Safety Software Market In 2026 And What Value Is Projected For 2030?
The pharmacovigilance and drug safety software market size has seen significant expansion in recent years. Its valuation is anticipated to climb from $2.53 billion in 2025 to $2.86 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.8%. The increase observed in previous periods can be attributed to a rise in adverse drug reaction reporting, the worldwide nature of clinical trials, rigorous drug safety regulations, an uptick in pharmaceutical manufacturing, and the escalating need for post-marketing surveillance.
The pharmacovigilance and drug safety software market size is projected to experience substantial growth in the upcoming years, with expectations to reach $4.6 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 12.6%. This expansion during the forecast period is fueled by the expansion of ai-driven signal detection, growth in biologics and specialty drugs, rising regulatory scrutiny, increasing outsourcing of pharmacovigilance services, and demand for real-time safety analytics. Additionally, prominent trends shaping the forecast period include the growing adoption of cloud-based pharmacovigilance platforms, increasing focus on real-world evidence monitoring, rising automation in adverse event reporting, expansion of integrated drug safety systems, and higher demand for regulatory compliance solutions.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19140&type=smp
What Major Drivers Are Influencing Demand In The Pharmacovigilance And Drug Safety Software Market?
The increasing need for personalized medicine is projected to stimulate expansion in the pharmacovigilance and drug safety software market in the future. Personalized medicine, alternatively termed precision medicine, represents a medical strategy that customizes treatment choices based on a person’s genetic makeup, biological profile, and lifestyle attributes. The uptake of personalized medicine is escalating because of better treatment results, advanced methods for prevention and early identification, and improved economic efficiency. The pharmacovigilance and drug safety software market aids personalized medicine through the integration of pharmacogenetics, real-time data analytics, and post-marketing surveillance, thereby optimizing patient safety, overseeing tailored treatments, and reinforcing risk-management procedures. As an example, in February 2024, data from the Personalized Medicine Coalition (PMC), a US-based non-profit organization, indicated that the FDA granted approval to 16 novel personalized therapies for individuals with rare diseases in 2023, which is an increase from 6 approvals recorded in 2022. Consequently, the expanding requirement for personalized medicine is fueling the growth of the pharmacovigilance and drug safety software market.
What Are The Key Segments Of The Pharmacovigilance And Drug Safety Software Market?
The pharmacovigilance and drug safety software market covered in this report is segmented –
1) By Software Type: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software
2) By Delivery Mode: On-premise, Cloud-based
3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, Other End Users
Subsegments:
1) By Adverse Event Reporting Software: Spontaneous Reporting Systems, EHR Integration Solutions, Mobile Reporting Applications
2) By Drug Safety Audits Software: Audit Management Solutions, Compliance Tracking Tools, Reporting And Analytics Modules
3) By Issue Tracking Software: Incident Reporting Systems, Workflow Management Tools, Collaboration Platforms
4) By Fully Integrated Software: Pharmacovigilance Platforms, Regulatory Compliance Systems, Data Analytics And Visualization Tools
What Key Trends Are Influencing The Development Of The Pharmacovigilance And Drug Safety Software Market?
Leading companies in the pharmacovigilance and drug safety software market are concentrating on developing innovative technologies, including cloud-based data lake platforms, to enhance adverse event monitoring, improve regulatory adherence, and boost overall patient safety across clinical trials and post-market surveillance. A cloud-based data lake platform is defined as a scalable, centralized system able to store and analyze vast quantities of structured and unstructured safety data in real time, enabling advanced analytics, AI/ML modeling, and streamlined case processing within pharmacovigilance workflows. For example, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, introduced CorEvidence, its proprietary cloud-based data lake platform, specifically designed to optimize pharmacovigilance processes by improving safety data management and case processing efficiency, especially for supporting post-authorization safety studies within clinical research registries.
Who Are The Leading Companies Operating In The Pharmacovigilance And Drug Safety Software Market?
Major companies operating in the pharmacovigilance and drug safety software market are IQVIA, Oracle Corporation, ArisGlobal, RXLogix, Anju Software Inc., EXTEDO GmbH, Sarjen Systems Pvt Ltd, Ennov Group, AB Cube, Clinevo Technologies, Accenture plc, International Business Machines Corporation, Capgemini SE, Cognizant Technology Solutions, Wipro Limited, Genpact, Indegene Limited, PharmaLex, Deloitte Touche Tohmatsu Limited, Parexel
Read the full pharmacovigilance and drug safety software market report here:
Which Region Shows The Strongest Potential For Future Growth In The Pharmacovigilance And Drug Safety Software Market?
North America was the largest region in the pharmacovigilance and drug safety software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance and drug safety software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Pharmacovigilance And Drug Safety Software Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=19140&type=smp
Browse Through More Reports Similar to the Global Pharmacovigilance And Drug Safety Software Market 2026, By The Business Research Company
Pharmacovigilance Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report
Patient Safety And Risk Management Software Market Report 2026
Therapeutic Drug Monitoring Market Report 2026
https://www.thebusinessresearchcompany.com/report/therapeutic-drug-monitoring-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model